Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
YTX-465
Cat. No.:
OB0225LY-0227
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR.
Size:
Product Overview
Description:
YTX-465 is a novel small molecule compound with multi-targeted biological activities involved in the regulation of cell signaling pathways.
Synonym:
2225824-53-1; Benzamide, N-[2-[4-[3-(1,3-dimethyl-1H-indazol-6-yl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-2-oxoethyl]-; N-[2-[4-[3-(1,3-Dimethyl-1H-indazol-6-yl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]-2-oxoethyl]benzamide; N-[2-[4-[3-(1,3-Dimethylindazol-6-yl)-1,2,4-oxadiazol-5-yl]piperidin-1-yl]-2-oxoethyl]benzamide
CAS No.:
2225824-53-1
Compound CID:
134477586
Formula:
C25H26N6O3
Formula Weight:
458.51
Specification
Relative Density:
1.38 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
YTX-465 can be used to study cell proliferation and apoptosis.
Library Information
Targets:
Stearoyl-CoA desaturase (SCD) family; Ole1
Pathways:
Metabolism
Plate Number:
AOCL-3
Plate Location:
g11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
50 mg/mL; 109.05 mM
